|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant, and equipment, net | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Wages and benefits payable | ||||||||||||||||||||
| Taxes payable | ||||||||||||||||||||
| Current portion of debt, net | ||||||||||||||||||||
| Current portion of warranty | ||||||||||||||||||||
| Unearned revenue | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt, net | ||||||||||||||||||||
| Long-term warranty | ||||||||||||||||||||
| Pension benefit obligation | ||||||||||||||||||||
| Deferred tax liabilities, net | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other long-term obligations | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Equity, Attributable to Parent | ||||||||||||||||||||
| Preferred stock, no par value, 10,000 shares authorized, no shares issued or outstanding | ||||||||||||||||||||
| Common stock, no par value, 150,000 shares authorized, 43,846 and 44,929 shares issued and outstanding | ||||||||||||||||||||
| Accumulated other comprehensive loss, net | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total Itron, Inc. shareholders' equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
| Common stock, shares authorized (in shares) |
Loading...
